Clinical Trials Logo

Clinical Trial Summary

Due to the concerns of virus transmission during COVID-19 pandemic, multiple respiratory societies postpone or limit pulmonary function test, especially cardiopulmonary exercise test (CPET), as patients may generate large amount of aerosol particles during test but it is conventionally performed without filter. This study aims to investigate the effects of reducing aerosol particle concentrations in the room air during CPET by placing an inline filter, and to assess the effects of filter on the physiologic responses during CPET.


Clinical Trial Description

The subject will spend two visits one hour each day (~ 1 hour) in the PFT lab and will have two separate CPET (Vmax Encore PFT System, Vyaire medical, Mettawa, IL) tests performed by registered pulmonary function technologists. One day the test will be performed with the inline filter during CPET, and the second day the CPET will be performed without a filter. During the test, electrocardiogram (ECG) electrodes will be attached to participants as well as a mask, and their heart rate will be measured for 10 minutes at rest, and then they will ride bicycle for 20 minutes at different levels of intensity. The work rate increment will be the same for both tests. All gas exchange and aerosol particle concentrations measures will be compared with Bland Altman analysis and paired t-testing. ;


Study Design


Related Conditions & MeSH terms

  • Transmission, Patient-Professional

NCT number NCT04526925
Study type Interventional
Source Rush University Medical Center
Contact
Status Terminated
Phase N/A
Start date August 29, 2020
Completion date September 18, 2020

See also
  Status Clinical Trial Phase
Completed NCT04681599 - Different Modalities in Reducing Airborne Particulate Concentrations During AGP for Health Volunteers N/A
Completed NCT04654754 - Aerosol Particle Concentrations Among Different Oxygen Devices for Spontaneous Breathing Patients With Tracheostomy N/A